Search research articles
Contact Us
Filters
Showing results (601-610 of 649) with videos related to
Page
of 65
Sort By:
Transfusion
|
October 14, 2009
CD34+ cells obtained from "good mobilizers" are more activated and exhibit lower ex vivo expansion efficiency than their counterparts from "poor mobilizers"
Zoran Ivanovic, Milica Kovacevic-Filipovic, Michel Jeanne, et al.
Blood
|
December 3, 1998
Response at three months is a good predictive factor for newly diagnosed chronic myeloid leukemia patients treated by recombinant interferon-alpha
F X Mahon, C Fabères, S Pueyo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 2, 2006
Results of genoidentical hemopoietic stem cell transplantation with reduced intensity conditioning for acute myelocytic leukemia: higher doses of stem cells infused benefit patients receiving transplants in second remission or beyond--the Acute Leukemia Working Party of the European Cooperative Group for Blood and Marrow Transplantation
Norbert-Claude Gorin, Myriam Labopin, Jean-Michel Boiron, et al.
Bone Marrow Transplantation
|
July 12, 2005
Cost effectiveness of day 5 G-CSF (Lenograstim) administration after PBSC transplantation: results of a SFGM-TC randomised trial
D Valteau-Couanet, C Faucher, A Aupérin, et al.
Anticancer Research
|
January 10, 2014
Characteristics and natural history of patients with colorectal cancer complicated by infectious endocarditis. Case control study of 25 patients
Mehdi Ouaïssi, Anne-Sophie Studer, Diane Mege, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 17, 2010
Hypoxia preconditioned mesenchymal stem cells improve vascular and skeletal muscle fiber regeneration after ischemia through a Wnt4-dependent pathway
Lionel Leroux, Betty Descamps, Nancy F Tojais, et al.
La Nouvelle Presse Medicale
|
October 5, 1974
[Initial therapy of Hodgkin's disease using polychemotherapy. Long-term results of 204 cases (1-8 year follow-up)]
C Jacquillat, M Weil, G Auclerc, et al.
Bone Marrow Transplantation
|
November 25, 1998
Factors influencing haemopoietic recovery following chemotherapy-mobilised autologous peripheral blood progenitor cell transplantation for haematological malignancies: a retrospective analysis of a 10-year single institution experience
R M Lowenthal, C Fabères, G Marit, et al.
BMC Genomics
|
April 30, 2013
The Nocardia cyriacigeorgica GUH-2 genome shows ongoing adaptation of an environmental Actinobacteria to a pathogen's lifestyle
Anthony Zoropogui, Petar Pujic, Philippe Normand, et al.
Leukemia
|
September 16, 1998
Factors affecting both peripheral blood progenitor cell mobilization and hematopoietic recovery following autologous blood progenitor cell transplantation in multiple myeloma patients: a monocentric study
G Marit, F Thiessard, C Faberes, et al.
Page
of 65
Search research articles
Search
Showing results (601-610 of 649) with videos related to
Sort By:
Page
of 65
Transfusion
|
October 14, 2009
CD34+ cells obtained from "good mobilizers" are more activated and exhibit lower ex vivo expansion efficiency than their counterparts from "poor mobilizers"
Zoran Ivanovic, Milica Kovacevic-Filipovic, Michel Jeanne, et al.
Blood
|
December 3, 1998
Response at three months is a good predictive factor for newly diagnosed chronic myeloid leukemia patients treated by recombinant interferon-alpha
F X Mahon, C Fabères, S Pueyo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 2, 2006
Results of genoidentical hemopoietic stem cell transplantation with reduced intensity conditioning for acute myelocytic leukemia: higher doses of stem cells infused benefit patients receiving transplants in second remission or beyond--the Acute Leukemia Working Party of the European Cooperative Group for Blood and Marrow Transplantation
Norbert-Claude Gorin, Myriam Labopin, Jean-Michel Boiron, et al.
Bone Marrow Transplantation
|
July 12, 2005
Cost effectiveness of day 5 G-CSF (Lenograstim) administration after PBSC transplantation: results of a SFGM-TC randomised trial
D Valteau-Couanet, C Faucher, A Aupérin, et al.
Anticancer Research
|
January 10, 2014
Characteristics and natural history of patients with colorectal cancer complicated by infectious endocarditis. Case control study of 25 patients
Mehdi Ouaïssi, Anne-Sophie Studer, Diane Mege, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 17, 2010
Hypoxia preconditioned mesenchymal stem cells improve vascular and skeletal muscle fiber regeneration after ischemia through a Wnt4-dependent pathway
Lionel Leroux, Betty Descamps, Nancy F Tojais, et al.
La Nouvelle Presse Medicale
|
October 5, 1974
[Initial therapy of Hodgkin's disease using polychemotherapy. Long-term results of 204 cases (1-8 year follow-up)]
C Jacquillat, M Weil, G Auclerc, et al.
Bone Marrow Transplantation
|
November 25, 1998
Factors influencing haemopoietic recovery following chemotherapy-mobilised autologous peripheral blood progenitor cell transplantation for haematological malignancies: a retrospective analysis of a 10-year single institution experience
R M Lowenthal, C Fabères, G Marit, et al.
BMC Genomics
|
April 30, 2013
The Nocardia cyriacigeorgica GUH-2 genome shows ongoing adaptation of an environmental Actinobacteria to a pathogen's lifestyle
Anthony Zoropogui, Petar Pujic, Philippe Normand, et al.
Leukemia
|
September 16, 1998
Factors affecting both peripheral blood progenitor cell mobilization and hematopoietic recovery following autologous blood progenitor cell transplantation in multiple myeloma patients: a monocentric study
G Marit, F Thiessard, C Faberes, et al.
Page
of 65